CRSP Operating Expenses
Crispr Therapeutics Ag · Operating Expenses
CRSP Operating Expenses
Latest reported$80.41Mperiod ending
CRSP Quarterly Operating Expenses ($2.64M → $80.41M)
Quarterly operating expenses
High-resolution chart · PNG
CRSP operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 80,405,000 | |
| 81,457,000 | |
| 96,264,000 | |
| 68,255,000 | |
| 84,210,000 | |
| 91,780,000 | |
| 99,588,000 | |
| 94,779,000 | |
| 94,801,000 | |
| 89,292,000 | |
| 110,417,000 | |
| 108,989,000 | |
| 120,587,000 | |
| 122,295,000 | |
| 124,724,000 | |
| 143,623,000 | |
| 149,496,000 | |
| 145,504,000 | |
| 23,678,000 | |
| 106,714,000 | |
| 110,639,000 | |
| 94,800,000 | |
| 25,766,000 | |
| 21,539,000 | |
| 21,353,000 | |
| 19,550,000 | |
| 17,272,000 | |
| 72,765,000 | |
| 55,301,000 | |
| 48,751,000 | |
| 45,343,000 | |
| 49,995,000 | |
| 38,374,000 | |
| 28,355,000 | |
| 31,353,000 | |
| 25,957,000 | |
| 24,888,000 | |
| 23,447,000 | |
| 27,654,000 | |
| 16,159,000 | |
| 17,353,000 | |
| 12,128,000 | |
| 12,413,000 | |
| 6,202,000 | |
| 2,110,000 | |
| 2,643,000 |